UCLA researchers have published findings showing that honey bee venom and its primary active compound, melittin, suppress cancer cell growth in two of the most aggressive and difficult-to-treat breast cancer subtypes.
The study used human breast cancer cell lines, and the results showed massive degradation of cell viability within 60 minutes of treatment.
Not 60 weeks, or 60 days. 60 minutes.
No current standard-of-care treatment, including chemotherapy, has shown results like this for these subtypes in that timeframe. The research is coming out of mainstream academia, published under a UCLA headline, and it is pointing squarely back toward the kind of outside-the-box, immune-system-centered thinking that a pharma-dominated research environment has spent decades crowding out.
Imagine where medicine could be right now if corporate interests had not had a stranglehold on research, regulatory agencies, and the news cycle for the last 50 years??
👇